We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$252M
AUM Growth
-$86.3M
Cap. Flow
-$109M
Cap. Flow %
-43.42%
Top 10 Hldgs %
38.06%
Holding
113
New
35
Increased
12
Reduced
16
Closed
45

Top Buys

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$11M
2
LH icon
Labcorp
LH
+$9.27M
3
MRK icon
Merck
MRK
+$8.29M
4
LIVN icon
LivaNova
LIVN
+$7.92M
5
ATHN
Athenahealth, Inc.
ATHN
+$5.37M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$10.7M
2
BCR
CR Bard Inc.
BCR
+$9.32M
3
GSK icon
GSK
GSK
+$8.25M
4
UNH icon
UnitedHealth
UNH
+$7.79M
5
CNC icon
Centene
CNC
+$7.73M

Sector Composition

Rank Sector Weight
1 Healthcare 65.96%
2 Industrials 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
76
DexCom
DXCM
$32B
– –
-140,000
Closed -$2.97M
FXH icon
77
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
– –
-100,000
Closed -$6.24M
GSK icon
78
GSK
GSK
$106B
– –
-156,500
Closed -$8.25M
HOLX
79
DELISTED
Hologic
HOLX
– –
-252,500
Closed -$10.7M
IWM icon
80
PUT
iShares Russell 2000 ETF
IWM
$81.9B
– –
-37,500
Closed -$5.16M
JAZZ icon
81
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-10,200
Closed -$1.48M
LLY icon
82
Eli Lilly
LLY
$1.06T
– –
-64,250
Closed -$5.4M
MEDP icon
83
Medpace
MEDP
$16.5B
– –
-145,282
Closed -$4.34M
PCRX icon
84
Pacira BioSciences
PCRX
$997M
– –
-42,500
Closed -$1.94M
PODD icon
85
Insulet
PODD
$9.79B
– –
-97,256
Closed -$4.19M
RVTY icon
86
Revvity
RVTY
$12.8B
– –
-119,500
Closed -$6.94M
SPY icon
87
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
– –
-50,000
Closed -$11.8M
SUPN icon
88
PUT
Supernus Pharmaceuticals
SUPN
$2.77B
– –
-105,000
Closed -$3.29M
TEVA icon
89
Teva Pharmaceuticals
TEVA
$41.2B
– –
-124,875
Closed -$4.01M
TFX icon
90
Teleflex
TFX
$5.98B
– –
-30,000
Closed -$5.81M
UHS icon
91
Universal Health Services
UHS
$10.5B
– –
-55,000
Closed -$6.84M
UNH icon
92
UnitedHealth
UNH
$370B
– –
-47,500
Closed -$7.79M
WAT icon
93
CALL
Waters Corp
WAT
$39.9B
– –
-35,000
Closed -$5.47M
XLV icon
94
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
– –
-50,000
Closed -$3.72M
SIEN
95
DELISTED
Sientra, Inc.
SIEN
– –
-50,480
Closed -$4.25M
DMK
96
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-3,214
Closed -$956K
ZYNE
97
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-30,000
Closed -$603K
NVCN
98
DELISTED
Neovasc Inc.
NVCN
– –
-14
Closed -$520K
SIOX
99
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-47,500
Closed -$5.68M
ABMD
100
CALL
DELISTED
Abiomed Inc
ABMD
– –
-34,000
Closed -$4.26M
1 2 3
4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q2 2017 Portfolio in Review

As of Q2 2017, Pura Vida Investments held 113 positions worth $252M, down 26% from $338M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $109M in Q2 2017, closing 45 positions and reducing 16 holdings. Its most notable exit was Hologic, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 74% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Express Scripts Holding Company worth $11.2M.

  • Pura Vida Investments's largest Q2 2017 buy was Express Scripts Holding Company: 174,700 shares worth $11.2M.
  • Pura Vida Investments added most to NanoString Technologies, Inc. in Q2 2017, an estimated $4.51M increase.
  • Pura Vida Investments's biggest Q2 2017 reduction was Exact Sciences, cutting an estimated $6.94M.
  • Pura Vida Investments fully exited Hologic in Q2 2017, selling an estimated $10.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $252M portfolio in Q2 2017.
  • Pura Vida Investments opened 35 new positions and closed 45 in Q2 2017.
  • Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $252M.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.